Funded Startups in Jersey City
The size distribution in Jersey City is highly top-heavy: the largest disclosed round is Soltage’s $260M (Series Unknown) on 2025-06-10, which dwarfs the n…
The size distribution in Jersey City is highly top-heavy: the largest disclosed round is Soltage’s $260M (Series Unknown) on 2025-06-10, which dwarfs the next-largest disclosed amounts shown (Asset Based Lending’s $175M on 2024-11-04 and BlockFi’s $350M on 2021-03-11 are both larger than most other entries, but among the mid-pack, Soltage stands out). In stage labeling, 9 of 29 rows carry “Series Unknown” and 2 of 29 rows have “undisclosed” amounts (EpiBone on 2024-11-08 and EDX Markets on 2023-06-20), so disclosed sizing is not uniform.
Time-wise, the 29 most recent rows span from 2020-06-22 (CrossTower, $6M) to 2025-11-01 (Lyzr, $8M). Concentration appears in the 2024–2025 window: multiple large financings recur across financial services, biotech, and healthcare—e.g., Agora’s $50M (2025-07-07), Character Biosciences’ $17M (2025-09-15), and Oishii’s $150M (2024-11-20).
Most recent rounds
29 shownRelated listings
Frequently asked
What stands out in round sizes for Jersey City, and is there a single dominant outlier?
Yes. Soltage’s $260M (Series Unknown) on 2025-06-10 is the largest disclosed amount in the list and is far above the typical disclosed rounds, with the next-largest disclosed amounts generally clustering well below it (e.g., Asset Based Lending $175M on 2024-11-04 and Oishii $150M on 2024-11-20).
How much of the list has non-standard or missing disclosed amounts (Series Unknown / undisclosed)?
9 of 29 rows are labeled “Series Unknown” (e.g., Soltage 2025-06-10 $260M; Asset Based Lending 2024-11-04 $175M), and 2 of 29 rows show “undisclosed” amounts (EpiBone on 2024-11-08 and EDX Markets on 2023-06-20). That combination means any size-based comparisons should lean on disclosed amounts only.
Are any sectors over-represented across the most recent 29 entries?
Financial services is the clearest cluster, appearing repeatedly (e.g., Agora $50M on 2025-07-07; Nukkleus $10M on 2024-12-18; ThreatModeler is IT rather than FS, while SageSure Insurance Managers $50M on 2023-03-28 and BlockFi $350M on 2021-03-11 reinforce the theme). Biotech and healthcare also recur, with biotech including Character Biosciences $17M (2025-09-15), Evergreen Theragnostics $26M (2024-04-16), and EpiBone (undisclosed, 2024-11-08).
Which entries fall near the most recent period, and how do their amounts compare?
Within roughly the latest 90 days shown, several sizable disclosed rounds appear, including Confido Health $10M (2025-10-01) and Character Biosciences $17M (2025-09-15), while Soltage’s $260M (2025-06-10) sits well above the rest of the same recent band. The newest dated entry is Lyzr on 2025-11-01 with $8M (Series A).
Is there a stage mix pattern worth noting when scanning for deal flow?
Series labels are split between named rounds and unclassified ones: “Series Unknown” occurs 9 times, including Soltage (2025-06-10, $260M) and Rising Tide Capital (2025-07-10, $2M), while multiple named rounds also recur (e.g., Series A includes Confido Health $10M on 2025-10-01; Agora $50M on 2025-07-07). Seed/pre-seed appears at the low end via HyperTunnel $20K (2023-04-03, Pre-Seed) and Hostify $100K (2021-05-01, stage blank).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.